Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ziqiang Zhang, Yingying Sun, Haojie Wang, Yuxiang Yang, Ruiqi Dong, Yaolu Xu, Mengyu Zhang, Qiongxia Lv, Xiaoguang Chen & Yumei Liu. (2023) Melatonin pretreatment can improve the therapeutic effect of adipose-derived stem cells on CCl4-induced liver fibrosis. Toxin Reviews 42:2, pages 559-572.
Read now
Read now
Sandra Milic, Ivana Mikolasevic, Irena Krznaric-Zrnic, Marija Stanic, Goran Poropat, Davor Stimac, Vera Vlahovic-Palcevski & Lidija Orlic. (2015) Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options. Drug Design, Development and Therapy 9, pages 4835-4845.
Read now
Read now
Articles from other publishers (4)
Josieli R Colares, Renata M Hartmann, Elizângela G Schemitt, Sandielly R B Fonseca, Marilda S Brasil, Jaqueline N Picada, Alexandre S Dias, Aline F Bueno, Cláudio A Marroni & Norma P Marroni. (2022) Melatonin prevents oxidative stress, inflammatory activity, and DNA damage in cirrhotic rats. World Journal of Gastroenterology 28:3, pages 348-364.
Crossref
Crossref
Lucienne Juillerat-Jeanneret, John-David Aubert, Josip Mikulic & Dela Golshayan. (2018) Fibrogenic Disorders in Human Diseases: From Inflammation to Organ Dysfunction. Journal of Medicinal Chemistry 61:22, pages 9811-9840.
Crossref
Crossref
Bárbara González-Fernández, Diana I. Sánchez, Javier González-Gallego & María J. Tuñón. (2017) Sphingosine 1-Phosphate Signaling as a Target in Hepatic Fibrosis Therapy. Frontiers in Pharmacology 8.
Crossref
Crossref
Aaron M. Gusdon, Ke-xiu Song & Shen Qu. (2014) Nonalcoholic Fatty Liver Disease: Pathogenesis and Therapeutics from a Mitochondria-Centric Perspective. Oxidative Medicine and Cellular Longevity 2014, pages 1-20.
Crossref
Crossref